Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteers.

about

Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteers.

Item

http://www.wikidata.org/entity/Q40683523

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Pharmacokinetics and tolerabil ...... es in healthy male volunteers.

@en

type

Item

label

Pharmacokinetics and tolerabil ...... es in healthy male volunteers.

@en

prefLabel

Pharmacokinetics and tolerabil ...... es in healthy male volunteers.

@en

P1476

Pharmacokinetics and tolerabil ...... es in healthy male volunteers.

@en

P2093

Boyce M

http://www.w3.org/2001/XMLSchema#string

Cass LM

http://www.w3.org/2001/XMLSchema#string

Dallow N

http://www.w3.org/2001/XMLSchema#string

Hardman TC

http://www.w3.org/2001/XMLSchema#string

Jones A

http://www.w3.org/2001/XMLSchema#string

Moore KH

http://www.w3.org/2001/XMLSchema#string

Prince WT

http://www.w3.org/2001/XMLSchema#string

P2860

CYP3A gene expression in human gut epithelium

Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors

Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

Longer-term immunologic effects and side effects of successful antiretroviral therapy.

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

Quantification of sleepiness: a new approach.

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

The human hepatic cytochromes P450 involved in drug metabolism.

HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase.

Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

P304

1098-1105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/00912700122012706

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11583478

http://www.w3.org/2001/XMLSchema#string